Despite significant progress in the field of therapy and management, chronic heart failure (CHF) still remains one of the most common causes of morbidity and mortality, especially among the elderly in Western countries. In particular, frequent episodes of decompensation and, consequently, repeated hospitalizations represent an unsustainable burden for national health systems and the cause of worsening quality of life. CHF is more prevalent in elderly women, who often have "peculiar" clinical characteristics and a more preserved ejection fraction caused by endothelial dysfunction and micro-vessel damage. At the moment, noninvasive technologies that are able to remotely monitor these patients are not widely available yet, and clinical trials are underway to evaluate invasive remote sensors. Unfortunately, implantable devices for identifying decompensation are not the most practical solution in the majority of of patients with chronic heart failure. In particular, they are hypothesized to have the possibility of monitoring patients by pro-B-type natriuretic peptide, ventricular repolarization variability, and bioimpedance cardiography at the first point of care, but new technology and clinical trials must be planned to address the development and spread of these emergent possibilities.

Chronic heart failure management. monitoring patients and intercepting exacerbations / Piccirillo, G.; Moscucci, F.; Sciomer, S.; Magri', Damiano. - In: REVIEWS IN CARDIOVASCULAR MEDICINE. - ISSN 1530-6550. - 24:7(2023). [10.31083/j.rcm2407208]

Chronic heart failure management. monitoring patients and intercepting exacerbations

Piccirillo G.;Moscucci F.
;
Sciomer S.;Magri' Damiano
2023

Abstract

Despite significant progress in the field of therapy and management, chronic heart failure (CHF) still remains one of the most common causes of morbidity and mortality, especially among the elderly in Western countries. In particular, frequent episodes of decompensation and, consequently, repeated hospitalizations represent an unsustainable burden for national health systems and the cause of worsening quality of life. CHF is more prevalent in elderly women, who often have "peculiar" clinical characteristics and a more preserved ejection fraction caused by endothelial dysfunction and micro-vessel damage. At the moment, noninvasive technologies that are able to remotely monitor these patients are not widely available yet, and clinical trials are underway to evaluate invasive remote sensors. Unfortunately, implantable devices for identifying decompensation are not the most practical solution in the majority of of patients with chronic heart failure. In particular, they are hypothesized to have the possibility of monitoring patients by pro-B-type natriuretic peptide, ventricular repolarization variability, and bioimpedance cardiography at the first point of care, but new technology and clinical trials must be planned to address the development and spread of these emergent possibilities.
2023
ECG markers; bioimpedance; heart failure; prognosis; repolarization; sex/gender peculiarities
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Chronic heart failure management. monitoring patients and intercepting exacerbations / Piccirillo, G.; Moscucci, F.; Sciomer, S.; Magri', Damiano. - In: REVIEWS IN CARDIOVASCULAR MEDICINE. - ISSN 1530-6550. - 24:7(2023). [10.31083/j.rcm2407208]
File allegati a questo prodotto
File Dimensione Formato  
Piccirillo_Chronic_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 8.75 MB
Formato Adobe PDF
8.75 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1727562
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact